Indoco Remedies Limited is a Public Limited Company domiciled in India and incorporated under the provision of the Companies Act, VII of 1913. Its Shares are listed on two stock exchanges in India i.e Bombay Stock Exchange and National Stock Exchange. The company has decades of presence in the Indian Pharma market and a strong foothold in the international market.

Indoco has strengthened its wings in the international markets and offers complete solutions, including product development, manufacture and supply of Finished Dosages, APIs and Intermediates to generic companies worldwide. The company has a large basket of products backed by ANDAs / eCTD Dossiers and Drug Master Files (DMFs).

Expertise in Research & Development, backward integration in API in select products, own CRO set-up, excellence in Finished Dosages manufacturing and a strong customer base will ensure consistent growth in the Company’s Domestic, as well as International business.

Business area of the company

Indoco Remedies is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). The Company caters to both domestic and International markets.

Indoco Remedies Ltd.

AMI Organics Ltd.

Advanced Enzyme Technologies Ltd.

Strides Pharma Science Ltd.

Wockhardt Ltd.

Aarti Drugs Ltd.

Hikal Ltd.

Shilpa Medicare Ltd.

FDC Ltd.

Marksans Pharma Ltd.

Unichem Laboratories Ltd.

Sequent Scientific Ltd.

Neuland Laboratories Ltd.

Gufic Biosciences Ltd.

Amrutanjan Health Care Ltd.

HDFC Bank Ltd.

ICICI Bank Ltd.

ITC Ltd.

Reliance Industries Ltd.

Tata Motors Ltd.

Market Cap	3,664 Cr		EPS	17.5		High	400.45
Stock P/E	22.7		Net Profit Margin	11.5		Low	395.05

Market Cap	3,664 Cr	ROE	18.5%
P/E Ratio(TTM)	22.7	EPS(TTM)	16.7
P/B Ratio	3.8	Dividend Yield	0.6%
Industry P/E	65.2	Book Value	105.2
		Face Value	2.0

INDOCO